Voyager Therapeutics Inc
NASDAQ:VYGR
Voyager Therapeutics Inc
NASDAQ:VYGR
Price:
3.74
USD
-5.56%
Market Closed
Market Cap:
$222.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Voyager Therapeutics Inc
NASDAQ:VYGR
|
US |
|
Shin Foong Specialty and Applied Materials Co Ltd
TWSE:6582
|
TW |
|
S
|
Sociedad Comercial del Plata SA
BCBA:COME
|
AR |
|
S
|
Shanghai Turbo Enterprises Ltd
SGX:AWM
|
CN |
|
S
|
Securemetric Bhd
KLSE:SMETRIC
|
MY |
|
Biesse SpA
MIL:BSS
|
IT |
|
Biotricity Inc
OTC:BTCY
|
US |
|
DSV A/S
CSE:DSV
|
DK |
|
I
|
Intops Co Ltd
KOSDAQ:049070
|
KR |
|
Hansard Global PLC
LSE:HSD
|
IM |
|
International Isotopes Inc
OTC:INIS
|
US |
|
Somany Ceramics Ltd
NSE:SOMANYCERA
|
IN |
|
M
|
MLP Group SA
WSE:MLG
|
PL |
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
TH |
|
Thai Beverage PCL
SGX:Y92
|
TH |
Balance Sheet
Balance Sheet Decomposition
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Balance Sheet Decomposition is not available for
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Balance Sheet
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
7
|
31
|
37
|
32
|
47
|
86
|
104
|
117
|
99
|
69
|
71
|
65
|
|
| Cash Equivalents |
0
|
7
|
31
|
37
|
32
|
47
|
86
|
104
|
117
|
99
|
69
|
71
|
65
|
|
| Short-Term Investments |
0
|
0
|
163
|
138
|
138
|
109
|
196
|
77
|
15
|
20
|
162
|
195
|
131
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
8
|
1
|
1
|
84
|
4
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
19
|
8
|
1
|
0
|
83
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Other Current Assets |
0
|
1
|
1
|
4
|
3
|
7
|
4
|
9
|
3
|
5
|
4
|
6
|
3
|
|
| Total Current Assets |
0
|
8
|
196
|
179
|
172
|
163
|
305
|
198
|
137
|
125
|
320
|
277
|
203
|
|
| PP&E Net |
0
|
3
|
3
|
8
|
10
|
13
|
47
|
62
|
55
|
33
|
30
|
48
|
42
|
|
| PP&E Gross |
0
|
3
|
3
|
8
|
10
|
13
|
47
|
62
|
55
|
33
|
30
|
48
|
42
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
3
|
5
|
8
|
12
|
16
|
17
|
15
|
16
|
19
|
|
| Long-Term Investments |
0
|
0
|
30
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
66
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
|
| Total Assets |
0
N/A
|
12
+11 400%
|
230
+1 896%
|
190
-17%
|
185
-3%
|
177
-4%
|
355
+100%
|
262
-26%
|
194
-26%
|
159
-18%
|
351
+120%
|
393
+12%
|
252
-36%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
2
|
1
|
1
|
1
|
1
|
4
|
1
|
1
|
3
|
2
|
4
|
5
|
|
| Accrued Liabilities |
0
|
1
|
3
|
7
|
12
|
10
|
25
|
18
|
20
|
11
|
20
|
21
|
20
|
|
| Short-Term Debt |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
20
|
7
|
3
|
21
|
47
|
8
|
31
|
59
|
43
|
24
|
2
|
|
| Total Current Liabilities |
4
|
3
|
24
|
14
|
16
|
32
|
76
|
27
|
51
|
73
|
65
|
50
|
27
|
|
| Long-Term Debt |
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
2
|
37
|
40
|
35
|
99
|
179
|
81
|
48
|
28
|
50
|
44
|
30
|
|
| Total Liabilities |
4
N/A
|
10
+158%
|
60
+486%
|
54
-11%
|
50
-6%
|
131
+159%
|
255
+95%
|
107
-58%
|
99
-8%
|
100
+2%
|
115
+15%
|
93
-19%
|
56
-40%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
22
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
21
|
50
|
90
|
161
|
269
|
313
|
276
|
347
|
394
|
261
|
326
|
446
|
|
| Additional Paid In Capital |
0
|
0
|
219
|
226
|
295
|
316
|
412
|
430
|
442
|
453
|
498
|
626
|
642
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
1
N/A
|
169
+15 273%
|
136
-20%
|
134
-1%
|
46
-65%
|
100
+114%
|
154
+55%
|
95
-38%
|
59
-38%
|
236
+301%
|
300
+27%
|
196
-35%
|
|
| Total Liabilities & Equity |
0
N/A
|
12
+11 400%
|
230
+1 896%
|
190
-17%
|
185
-3%
|
177
-4%
|
355
+100%
|
262
-26%
|
194
-26%
|
159
-18%
|
351
+120%
|
393
+12%
|
252
-36%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
26
|
26
|
26
|
26
|
32
|
32
|
37
|
37
|
38
|
39
|
44
|
55
|
59
|
|
Switch to:
Switch to:
See Also
Discover More
